Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site
Authors:
- 1 August 2018
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 156, 162-179
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation of China (81773375, 81572995)
- National Major Scientific and Technological Special Project (2018ZX09201001-004-008, 2007ZX09302-010-005-003)
This publication has 44 references indexed in Scilit:
- Design and Characterization of Modular Scaffolds for Tubulin AssemblyJournal of Biological Chemistry, 2012
- Synthesis and Evaluation of 1,5-Disubstituted Tetrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative and Antitumor ActivityJournal of Medicinal Chemistry, 2011
- Design and synthesis of novel enhanced water soluble hydroxyethyl analogs of combretastatin A-4Bioorganic & Medicinal Chemistry Letters, 2011
- The identification a novel, selective, non-steroidal, functional glucocorticoid receptor antagonistBioorganic & Medicinal Chemistry Letters, 2010
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Class III β-tubulin expression and in vitro resistance to microtubule targeting agentsBritish Journal of Cancer, 2009
- Variations in the colchicine-binding domain provide insight into the structural switch of tubulinProceedings of the National Academy of Sciences, 2009
- [20] Processing of X-ray diffraction data collected in oscillation mode1997
- Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4Cellular and Molecular Life Sciences, 1989
- Beyond self-assembly: From microtubules to morphogenesisCell, 1986